Parallax Volatility Advisers’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-86,340
Closed -$174K 3474
2022
Q1
$174K Buy
+86,340
New +$170K ﹤0.01% 2227
2019
Q4
Sell
-264,320
Closed -$1.92M 2730
2019
Q3
$1.04M Buy
+264,320
New +$2.14M ﹤0.01% 1360
2019
Q1
Sell
-70,291
Closed -$1.76M 4332
2018
Q4
$1.26M Buy
70,291
+48,453
+222% +$990K ﹤0.01% 1227
2018
Q3
$641K Buy
+21,838
New +$845K ﹤0.01% 1379
2018
Q1
Sell
-8,067
Closed -$549K 4717
2017
Q4
$549K Sell
8,067
-16,095
-67% -$1.13M ﹤0.01% 1476
2017
Q3
$1.99M Buy
24,162
+23,769
+6,048% +$1.88M ﹤0.01% 849
2017
Q2
$37K Buy
393
+371
+1,686% +$22.7K ﹤0.01% 1853
2017
Q1
$1K Buy
+22
New +$1.34K ﹤0.01% 3444
2016
Q4
Sell
-12,230
Closed -$430K 4424
2016
Q3
$441K Buy
+12,230
New +$262K ﹤0.01% 1540
2016
Q1
Sell
-1,000
Closed -$35K 3972
2015
Q4
$35K Buy
+1,000
New +$64.5K ﹤0.01% 2433

Other funds holding CLVS